Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis

Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis

Background: Allogeneic hematopoietic stem cell transplantation (alloHSCT) has been proposed as curative approach for advanced cutaneous T–cell lymphomas (CTCL). Currently, there is no established consensus for the management of disease relapse after alloHSCT.Results: Ten patients, previously treated...

Full description

Bibliographic Details
Main Authors: Florentia Dimitriou, Urs Schanz, Gayathri Nair, Susanne Kimeswenger, Marie-Charlotte Brüggen, Wolfram Hoetzenecker, Lars E. French, Reinhard Dummer, Antonio Cozzio, Emmanuella Guenova
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Medicine
Subjects:
allogeneic stem cell transplantation
cutaneous T-cell lymphoma
Sézary syndrome
mycosis fungoides
interferon alpha-2a
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00290/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.00290/full

Similar Items